TY - JOUR
T1 - Preferable Transplant Site for Hepatocyte Transplantation in a Rat Model
AU - Ogasawara, Hiroyuki
AU - Inagaki, Akiko
AU - Fathi, Ibrahim
AU - Imura, Takehiro
AU - Yamana, Hiroki
AU - Saitoh, Yoshikatsu
AU - Matsumura, Muneyuki
AU - Fukuoka, Kengo
AU - Miyagi, Shigehito
AU - Nakamura, Yasuhiro
AU - Ohashi, Kazuo
AU - Unno, Michiaki
AU - Kamei, Takashi
AU - Goto, Masafumi
N1 - Funding Information:
The authors thank Kozue Imura (Division of Transplantation and Regenerative Medicine, Tohoku University) and Megumi Goto (Division of Transplantation and Regenerative Medicine, Tohoku University) for their excellent technical assistance, Prof. Yuji Nishikawa (Division of Tumor Pathology, Department of Pathology, Asahikawa Medical University), Norihiko Shimizu (Animal Laboratory for Medical Research, Asahikawa Medical University), Hironobu Chiba (Animal Laboratory for Medical Research, Asahikawa Medical University), Chihiro Hino (Animal Laboratory for Medical Research, Asahikawa Medical University), Tomomi Kibushi (Animal Laboratory, Tohoku University), and Keisuke Nishio (Animal Laboratory, Tohoku University) for breeding and taking care of the analbuminemic rats and Prof. Eiji Kobayashi (Department of Organ Fabrication, Keio University School of Medicine) for providing the luciferase transgenic rats to us. The authors also acknowledge the support of the Biomedical Research Core of Tohoku University, Graduate School of Medicine and TAMRIC (Tohoku Advanced Medical Research and Incubation Center).
Funding Information:
The authors thank Kozue Imura (Division of Transplantation and Regenerative Medicine, Tohoku University) and Megumi Goto (Division of Transplantation and Regenerative Medicine, Tohoku University) for their excellent technical assistance, Prof. Yuji Nishikawa (Division of Tumor Pathology, Department of Pathology, Asahikawa Medical University), Norihiko Shimizu (Animal Laboratory for Medical Research, Asahikawa Medical University), Hironobu Chiba (Animal Laboratory for Medical Research, Asahikawa Medical University), Chihiro Hino (Animal Laboratory for Medical Research, Asahikawa Medical University), Tomomi Kibushi (Animal Laboratory, Tohoku University), and Keisuke Nishio (Animal Laboratory, Tohoku University) for breeding and taking care of the analbuminemic rats and Prof. Eiji Kobayashi (Department of Organ Fabrication, Keio University School of Medicine) for providing the luciferase transgenic rats to us. The authors also acknowledge the support of the Biomedical Research Core of Tohoku University, Graduate School of Medicine and TAMRIC (Tohoku Advanced Medical Research and Incubation Center). The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was partly supported by the Japanese Grant-in-Aid for Scientific Research (A) (Grant Number 18H04056), (B) (Grant Number 15H04916) and (C) (Grant Number 16K01355) from the Japan Society for the Promotion of Science (JSPS). The founders played no role in the study design, the collection or analysis of the data, the decision to publish or the preparation of the manuscript.
Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was partly supported by the Japanese Grant-in-Aid for Scientific Research (A) (Grant Number 18H04056), (B) (Grant Number 15H04916) and (C) (Grant Number 16K01355) from the Japan Society for the Promotion of Science (JSPS). The founders played no role in the study design, the collection or analysis of the data, the decision to publish or the preparation of the manuscript.
Publisher Copyright:
© The Author(s) 2021.
PY - 2021
Y1 - 2021
N2 - Intraportal injection is regarded as the current standard procedure of hepatocyte transplantation (HTx). In islet transplantation, which shares many aspects with HTx, recent studies have clarified that instant blood-mediated inflammatory reaction (IBMIR), characterized by strong innate immune responses, can cause poor engraftment, so other transplant sites to avoid such a reaction have been established. Although IBMIR was reported to occur in HTx, few reports have evaluated alternative transplant sites for HTx. In this study, we sought to determine the optimum transplant site for HTx. Rat hepatocytes (1.0 × 107) were transplanted at the 9 transplant sites (intraportal (IPO), intrasplenic (IS), liver parenchyma, subcutaneous, intraperitoneal, renal subcapsular, muscle, inguinal subcutaneous white adipose tissue, and omentum) of analbuminemic rats. The serum albumin levels, immunohistochemical staining (albumin, TUNEL, and BrdU), and in vivo imaging of the grafts were evaluated. The serum albumin levels of the IPO group were significantly higher than those of the other groups (p <.0001). The BrdU-positive hepatocyte ratio of liver in the IS group (0.9% ± 0.2%) was comparable to that of the IPO group (0.9% ± 0.3%) and tended to be higher than that of the spleen in the IS group (0.5% ± 0.1%, p =.16). Considering the in vivo imaging evaluation and the influence of splenectomy, the graft function in the IS group may be almost entirely achieved by hepatocytes that have migrated to the liver.
AB - Intraportal injection is regarded as the current standard procedure of hepatocyte transplantation (HTx). In islet transplantation, which shares many aspects with HTx, recent studies have clarified that instant blood-mediated inflammatory reaction (IBMIR), characterized by strong innate immune responses, can cause poor engraftment, so other transplant sites to avoid such a reaction have been established. Although IBMIR was reported to occur in HTx, few reports have evaluated alternative transplant sites for HTx. In this study, we sought to determine the optimum transplant site for HTx. Rat hepatocytes (1.0 × 107) were transplanted at the 9 transplant sites (intraportal (IPO), intrasplenic (IS), liver parenchyma, subcutaneous, intraperitoneal, renal subcapsular, muscle, inguinal subcutaneous white adipose tissue, and omentum) of analbuminemic rats. The serum albumin levels, immunohistochemical staining (albumin, TUNEL, and BrdU), and in vivo imaging of the grafts were evaluated. The serum albumin levels of the IPO group were significantly higher than those of the other groups (p <.0001). The BrdU-positive hepatocyte ratio of liver in the IS group (0.9% ± 0.2%) was comparable to that of the IPO group (0.9% ± 0.3%) and tended to be higher than that of the spleen in the IS group (0.5% ± 0.1%, p =.16). Considering the in vivo imaging evaluation and the influence of splenectomy, the graft function in the IS group may be almost entirely achieved by hepatocytes that have migrated to the liver.
KW - IVIS
KW - hepatocyte transplantation
KW - portal
KW - spleen
KW - transplant site
UR - http://www.scopus.com/inward/record.url?scp=85115057174&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85115057174&partnerID=8YFLogxK
U2 - 10.1177/09636897211040012
DO - 10.1177/09636897211040012
M3 - Article
C2 - 34525872
AN - SCOPUS:85115057174
SN - 0963-6897
VL - 30
JO - Cell Transplantation
JF - Cell Transplantation
ER -